GHK-Cu Copper Tripeptide Research Compound Compound Name: GHK-Cu (Copper Tripeptide) Classification: Research Peptide Copper-Binding Tripeptide Complex Description: GHK-Cu is a synthetic copper-binding tripeptide composed of glycyl-L-histidyl-L-lysine (GHK) complexed with a divalent copper ion (Cu)
Using ChatGPT to independently assess treatment photos (and finding it aligned within 7.5% of dermatologists) demonstrates a scalable approach for future studies
Injection Site Reactions: For trials using injectable administration routes, local reactions at injection sites were monitored
Food and Drug Administration (FDA) has not approved Epitalon for the treatment of insomnia or any sleep disorder, though the FDAs Pharmacy Compounding Advisory Committee has scheduled a review of Epitalon for insomnia as of 2026
From a broader perspective, personal health behavior is connected to planetary health and can significantly contribute to preserving and maintaining human development (185, 188)
How it works Ordering takes one message No account, no checkout forms